Preventing Breast Cancer Metastasis With Conjugate Vaccines Targeting Human HER2
The aim of this novel and ambitious project is to develop potent new vaccines with potential to prevent recurrence of HER2 positive breast cancer. This is made possible through the team’s prior experience and the availability of partially tested vaccines, cell lines and animal strains and through collaboration. It is expected that the differing chemical structures of the vaccines will elicit and prime, immune responses in different tissue compartments, (lung, stomach and liver). Metastasis is a devastating complication of breast cancer, and tumours over-expressing human epidermal growth factor receptor 2 (HER2) carry higher risk.
Keep reading
View all
Can Functional MRI of the Brain help us understand Brain Fog in Women with Breast Cancer?
Up to 70% of women with breast cancer experience cognitive difficulties, but scientists still don't fully understand why this happens. Without a clear understanding of the underlying cause, it is d...
Exploring Better Breast Imaging for Women in Aotearoa New Zealand
Mammograms save lives by finding breast cancer early. But they do not work equally well for everyone.For women with very dense breast tissue, cancer can be harder to see on a standard mammogram. Th...
From Evidence to Action: Expanding the ‘Not a One-Size-Fits-All’ Breast Cancer Screening Model for Aotearoa New Zealand.
Breast cancer screening in Aotearoa New Zealand does not benefit all women equally. Many cancers are still found outside the national screening programme, and Māori and Pacific women can face delay...
